Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


NuPathe Inc. 

375 East Elm Street
Suite 110
Conshohocken  Pennsylvania  19428  U.S.A.
Phone: 484-567-0130 Fax: 484-567-0136



 Company News
Teva Pharmaceutical Industries Limited (TEVA) Completes Tender Offer For NuPathe Inc. (PATH) Shares 2/21/2014 8:47:20 AM
NuPathe Inc. (PATH) Dumps Merger Deal With Endo Health Solutions Inc. (ENDP) In Favor Of Teva Pharmaceutical Industries Limited (TEVA)'s $144 Million Offer 1/21/2014 6:36:55 AM
Teva Pharmaceutical Industries Limited (TEVA) Seeks To Outbid Rival Endo Health Solutions Inc. (ENDP) With $114 Million NuPathe Inc. (PATH) Offer 1/8/2014 7:19:15 AM
Endo Health Solutions Inc. (ENDP) Bags NuPathe Inc. (PATH) In $105 Million Deal 12/16/2013 7:12:23 AM
NuPathe Inc. (PATH) Announces Third Quarter 2013 Financial Results And Recent Operational Highlights 11/18/2013 12:41:28 PM
NuPathe Inc. (PATH) Doses Adolescent Migraineurs in Clinical Study of ZECUITY 9/23/2013 10:03:24 AM
NuPathe Inc. (PATH) Announces Allowance of Additional U.S. Patent for ZECUITY 9/11/2013 9:03:05 AM
NuPathe Inc. (PATH) Announces Allowance of Additional U.S. Patent Application for NP201 5/13/2013 11:50:25 AM
NuPathe Inc. (PATH) to Host Conference Call to Discuss First Quarter 2013 Results on Tuesday, May 14, 2013 5/7/2013 10:59:59 AM
NuPathe Inc. (PATH) Announces Allowance of U.S. Patent Application for NP201 4/25/2013 7:27:20 AM